Point-of-care rapid test for quantifying C-reactive protein in serum samples. Applied for acute phase response assessment and infection monitoring in healthcare settings.
Manufactured by
Prometheus Bio Inc.
China
Prometheus Bio Inc., established in 2007, specializes in R&D, manufacturing, and sales of in-vitro diagnostic reagents. The company was the first Asian manufacturer to receive FDA approval for drugs of abuse testing products. Products are registered with China NMPA, US FDA, and CE, covering five major categories: drugs of abuse, women's health, infectious diseases, cardiac markers, and tumor markers. Drug testing products support hair, urine, and saliva samples.
© 2026 Suplivia · Home · Browse Products